Emily A. Silverman

441 total citations
11 papers, 255 citations indexed

About

Emily A. Silverman is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Emily A. Silverman has authored 11 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Emily A. Silverman's work include Bone health and treatments (3 papers), Bone health and osteoporosis research (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Emily A. Silverman is often cited by papers focused on Bone health and treatments (3 papers), Bone health and osteoporosis research (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Emily A. Silverman collaborates with scholars based in United States. Emily A. Silverman's co-authors include K.Shahid Salles, Joann Labruyere, Madelon T. Price, John W. Olney, Gregory E. Frierdich, Francisco M. Marty, Cameron T. Nutt, Aaron Richterman, Robert R. Recker and Elizabeth Lyden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Antimicrobial Agents and Chemotherapy and European Journal of Pharmacology.

In The Last Decade

Emily A. Silverman

9 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily A. Silverman United States	7	106	72	52	40	23	11	255
Franziska Hartung Germany	10	215 2.0×	46 0.6×	30 0.6×	18 0.5×	26 1.1×	13	362
Andrew Levi United States	11	138 1.3×	73 1.0×	8 0.2×	14 0.3×	13 0.6×	15	651
Jodi L. Bubenik United States	11	266 2.5×	91 1.3×	40 0.8×	36 0.9×	7 0.3×	18	439
Varsha Iyer United States	8	95 0.9×	57 0.8×	83 1.6×	9 0.2×	14 0.6×	17	280
Santiago Cadena-Ullauri Ecuador	11	100 0.9×	17 0.2×	25 0.5×	22 0.6×	24 1.0×	39	301
Mitsuo Toyoshima Japan	9	78 0.7×	18 0.3×	62 1.2×	21 0.5×	16 0.7×	24	253
Petter Holland Norway	14	264 2.5×	15 0.2×	30 0.6×	49 1.2×	15 0.7×	24	565
Emi Tanaka Japan	10	105 1.0×	42 0.6×	7 0.1×	12 0.3×	5 0.2×	15	354
Andrea M. Amitrano United States	10	158 1.5×	20 0.3×	16 0.3×	8 0.2×	51 2.2×	11	342

Countries citing papers authored by Emily A. Silverman

Since Specialization

Citations

This map shows the geographic impact of Emily A. Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily A. Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily A. Silverman more than expected).

Fields of papers citing papers by Emily A. Silverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily A. Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily A. Silverman. The network helps show where Emily A. Silverman may publish in the future.

Co-authorship network of co-authors of Emily A. Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of Emily A. Silverman. A scholar is included among the top collaborators of Emily A. Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily A. Silverman. Emily A. Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Eucker, Stephanie A., Kristin L. Rising, Kelli N. O’Laughlin, et al.. (2024). An evaluation of COVID‐19 vaccine messaging platforms in the emergency department. Academic Emergency Medicine. 31(9). 933–936.

Cheng, Alexandre Pellan, Matthew P. Cheng, Joan Sesing Lenz, et al.. (2022). Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation. Proceedings of the National Academy of Sciences. 119(4). 29 indexed citations

Chen, Kaiwen, Matthew P. Cheng, Anne McDonnell, et al.. (2021). Cytomegalovirus events in high‐risk allogeneic hematopoietic‐cell transplantation patients who received letermovir prophylaxis. Transplant Infectious Disease. 23(4). e13619–e13619. 9 indexed citations

Silverman, Emily A., et al.. (2021). Future studies using histomorphometry in type 1 diabetes mellitus. Current Opinion in Endocrinology Diabetes and Obesity. 28(4). 371–376. 2 indexed citations

Silverman, Emily A., et al.. (2021). Abstract #1003792: A Case of Posaconazole Induced Primary Adrenal Insufficiency. Endocrine Practice. 27(6). S15–S15.

Silverman, Emily A., et al.. (2021). Abstract #1003673: Normocalcemic Primary Hyperparathyroidism Post Bariatric Surgery. Endocrine Practice. 27(6). S99–S100. 1 indexed citations

Silverman, Emily A., et al.. (2020). Trabecular bone score and transilial bone trabecular histomorphometry in type 1 diabetes and healthy controls. Bone. 137. 115451–115451. 18 indexed citations

Silverman, Emily A., et al.. (2020). New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19. Antimicrobial Agents and Chemotherapy. 65(1). 54 indexed citations

Burns, Melissa, Gayle P. Pouliot, Kristen E. Stevenson, et al.. (2018). Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia. Leukemia. 32(10). 2126–2137. 44 indexed citations

10.

Silverman, Emily A.. (2013). Adolescent sexual risk-taking in a psychosocial context: implications for HIV prevention.. PubMed. 25(2). 1–5. 6 indexed citations

11.

Olney, John W., Madelon T. Price, Joann Labruyere, et al.. (1987). Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. European Journal of Pharmacology. 142(2). 319–320. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact